Abstract:BACKGROUND Colorectal cancer stem cells (CCSCs) are heterogeneous cells that can self-renew and undergo multidirectional differentiation in colorectal cancer (CRC) patients. CCSCs are generally accepted to be important sources of CRC and are responsible for the progression, metastasis, and therapeutic resistance of CRC. Therefore, targeting this specific subpopulation has been recognized as a promising strategy for overcoming CRC. AIM To investigate the effect of VX-509 on CCSCs and elucidate the underlying mechanism. METHODS CCSCs were enriched from CRC cell lines by in conditioned serum-free medium. Western blot, Aldefluor, transwell and tumorigenesis assays were performed to verify the phenotypic characteristics of the CCSCs. The anticancer efficacy of VX-509 was assessed in HCT116 CCSCs and HT29 CCSCs by performing cell viability analysis, colony formation, sphere formation, flow cytometry, and western blotting assessments in vitro and tumor growth, immunohistochemistry and immunofluorescence assessments in vivo . RESULTS Compared with parental cells, sphere cells derived from HCT116 and HT29 cells presented increased expression of stem cell transcription factors and stem cell markers and were more potent at promoting migration and tumorigenesis, demonstrating that the CRC sphere cells displayed CSC features. VX-509 inhibited the tumor malignant biological behavior of CRC-stem-like cells, as indicated by their proliferation, migration and clonality in vitro , and suppressed the tumor of CCSC-derived xenograft tumors in vivo . Besides, VX-509 suppressed the CSC characteristics of CRC-stem-like cells and inhibited the progression of epithelial-mesenchymal transition (EMT) signaling in vitro . Nodal was identified as the regulatory factor of VX-509 on CRC stem-like cells through analyses of differentially expressed genes and CSC-related database information. VX-509 markedly downregulated the expression of Nodal and its downstream phosphorylated Smad2/3 to inhibit EMT progression. Moreover, VX-509 reversed the dedifferentiation of CCSCs and inhibited the progression of EMT induced by Nodal overexpression. CONCLUSION VX-509 prevents the EMT process in CCSCs by inhibiting the transcription and protein expression of Nodal, and inhibits the dedifferentiated self-renewal of CCSCs.

Nodal promotes colorectal cancer survival and metastasis through regulating SCD1-mediated ferroptosis resistance

Nodal Promotes the Self-Renewal of Human Colon Cancer Stem Cells Via an Autocrine Manner Through Smad2/3 Signaling Pathway.

Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway.

Increasing Embryonic Morphogen Nodal Expression Suggests Malignant Transformation in Colorectal Lesions and As a Potential Marker for CMS4 Subtype of Colorectal Cancer

Numb Negatively Regulates the Epithelial-to-mesenchymal Transition in Colorectal Cancer Through the Wnt Signaling Pathway.

CircCTNNA1 Acts As a Cerna for Mir-363-3p to Facilitate the Progression of Colorectal Cancer by Promoting CXCL5 Expression

Endogenous Nodal Promotes Melanoma Undergoing Epithelial-Mesenchymal Transition Via Snail and Slug in Vitro and in Vivo.

Nodal Signaling Activates the Smad2/3 Pathway to Regulate Stem Cell-Like Properties in Breast Cancer Cells.

Nodal Signaling Modulates the Expression of Oct-4 Via Nuclear Translocation of Β-Catenin in Lung and Prostate Cancer Cells

Nodal Promotes Glioblastoma Cell Growth

Nodosin Exerts an Anti-Colorectal Cancer Effect by Inhibiting Proliferation and Triggering Complex Cell Death in Vitro and in Vivo

Nodal Promotes the Generation of M2-Like Macrophages and Downregulates the Expression of Il-12

Cancer Stem Cell Regulated Phenotypic Plasticity Protects Metastasized Cancer Cells from Ferroptosis

Nodal promotes aggressive phenotype via Snail-mediated epithelial-mesenchymal transition in murine melanoma.

Nodal Enhances Perineural Invasion in Pancreatic Cancer by Promoting Tumor-Nerve Convergence.

VX-509 attenuates the stemness characteristics of colorectal cancer stem-like cells by regulating the epithelial-mesenchymal transition through Nodal/Smad2/3 signaling

Nodal Activates Smad and Extracellular Signal-Regulated Kinases 1/2 Pathways Promoting Renal Cell Carcinoma Proliferation.

Expression and Significance of Nodal in Human Cancers: a Meta-Analysis.

Nodal Induces Epithelial-Mesenchymal Transition in Gallbladder Carcinoma Via the Smad2/4 Pathway

SNORD1C maintains stemness and 5-FU resistance by activation of Wnt signaling pathway in colorectal cancer

Original Article Expression and Significance of Nodal in Human Cancers: a Meta-Analysis